Jan 16, 2017 7:30am EST Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Nov 01, 2016 4:01pm EDT Rigel Announces Third Quarter 2016 Financial Results and Provides Company Update
Oct 28, 2016 7:30am EDT Rigel Announces Conference Call and Webcast to Report Third Quarter 2016 Financial Results
Oct 20, 2016 7:00am EDT Rigel Announces Results from the Second FIT Phase 3 Study and the Long-Term Open-Label Extension Study for Fostamatinib in ITP
Oct 10, 2016 10:00pm EDT Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
